Literature DB >> 4791309

Enzymatic acetylation as a means of determining serum aminoglycoside concentrations.

M J Haas, J Davies.   

Abstract

A rapid and accurate enzymatic assay has been developed for the determination of blood serum levels of BB-K8 and other suitable aminoglycoside antibiotics.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4791309      PMCID: PMC444583          DOI: 10.1128/AAC.4.4.497

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  A rapid chemical assay for gentamicin.

Authors:  D H Smith; B Van Otto; A L Smith
Journal:  N Engl J Med       Date:  1972-03-16       Impact factor: 91.245

2.  Chloramphenicol-, dihydrostreptomycin-, and kanamycin-inactivating enzymes from multiple drug-resistant Escherichia coli carrying episome 'R'.

Authors:  S Okamoto; Y Suzuki
Journal:  Nature       Date:  1965-12-25       Impact factor: 49.962

3.  Enzymatic acetylation of aminoglycoside antibiotics by Escherichia coli carrying an R factor.

Authors:  R Benveniste; J Davies
Journal:  Biochemistry       Date:  1971-05-11       Impact factor: 3.162

4.  Isolation and structure of kanamycin inactivated by a cell free system of kanamycin-resistant E. coli.

Authors:  H Umezawa; M Okanishi; R Utahara; K Maeda; S Kondo
Journal:  J Antibiot (Tokyo)       Date:  1967-07       Impact factor: 2.649

5.  Gentamicin resistance in strains of Pseudomonas aeruginosa mediated by enzymatic N-acetylation of the deoxystreptamine moiety.

Authors:  M Brzezinska; R Benveniste; J Davies; P J Daniels; J Weinstein
Journal:  Biochemistry       Date:  1972-02-29       Impact factor: 3.162

  5 in total
  21 in total

1.  Properties of the gentamicin acetyltransferase enzyme and application to the assay of aminoglycoside antibiotics.

Authors:  J M Broughall; D S Reeves
Journal:  Antimicrob Agents Chemother       Date:  1975-08       Impact factor: 5.191

2.  Comparison of a radioimmunoassay with an enzymatic assay for gentamicin.

Authors:  B H Minshew; R K Holmes; C R Baxter
Journal:  Antimicrob Agents Chemother       Date:  1975-01       Impact factor: 5.191

3.  Improved acetylating radioenzymatic assay of amikacin, tobramycin, and sisomicin in serum.

Authors:  P Stevens; L S Young; W L Hewitt
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

4.  Improved radioenzymatic assay for spectinomycin.

Authors:  J G Cannon; C P Moran; K F Bott
Journal:  Antimicrob Agents Chemother       Date:  1978-08       Impact factor: 5.191

5.  Effects of divalent cations on binding of aminoglycoside antibiotics to human serum proteins and to bacteria.

Authors:  C H Ramirez-Ronda; R K Holmes; J P Sanford
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

6.  Enzymatic adenylylation by aminoglycoside 4'-adenylytransferase and 2"-adenylyltransferase as a means of determining concentrations of aminoglycoside antibiotics in serum.

Authors:  P Santanam; F H Kayser
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

7.  Effects of gestational age, birth weight, and hypoxemia on pharmacokinetics of amikacin in serum of infants.

Authors:  M G Myers; R J Roberts; N J Mirhij
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

8.  Concentrations of gentamicin and amikacin in human kidneys.

Authors:  C Q Edwards; C R Smith; K L Baughman; J F Rogers; P S Lietman
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

9.  Inhibition of acetylating activity in an enzymatic assay for aminoglycoside antibiotics.

Authors:  B H Minshew; S R Swanzy; F D Schoenknecht
Journal:  Antimicrob Agents Chemother       Date:  1977-11       Impact factor: 5.191

10.  Amikacin pharmacokinetics in pediatric patients with malignancy.

Authors:  T G Cleary; L K Pickering; W G Kramer; S Culbert; L S Frankel; S Kohl
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.